| Date Filed | Type | Description |
| 10/10/2023 |
4
| DeSimone Jill (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Bought 14,500 shares
@ $1.75, valued at
$25.4k
|
|
| 10/04/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/03/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.4% stake in Praxis Precision Medicines, Inc. |
| 06/30/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6.2% stake in Praxis Precision Medicines, Inc. |
| 06/30/2023 |
SC 13G
| Venrock Healthcare Capital Partners III, L.P. reports a 9.1% stake in Praxis Precision Medicines, Inc. |
| 06/28/2023 |
SC 13D/A
| Velan Capital Investment Management LP reports a 4% stake in Praxis Precision Medicines, Inc. |
| 06/16/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 06/15/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 06/15/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/09/2023 |
8-K
| Other Events Interactive Data |
| 06/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.7% stake in PRAXIS PRECISION MEDICINES, INC. |
| 05/18/2023 |
4
| Kelly Timothy Edwin (CFO) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Granted 11,683 shares
@ $0.884, valued at
$10.3k
|
|
| 05/18/2023 |
4
| Nemiroff Alex (General Counsel and Secretary) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Granted 11,686 shares
@ $0.884, valued at
$10.3k
|
|
| 05/18/2023 |
4
| Souza Marcio (CEO) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Granted 11,687 shares
@ $0.884, valued at
$10.3k
|
|
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
4
| Souza Marcio (CEO) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Bought 35,000 shares
@ $0.8617, valued at
$30.2k
Bought 35,002 shares
@ $0.863, valued at
$30.2k
|
|
| 03/27/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8363, valued at
$41.8k
|
|
| 03/27/2023 |
4
| Kelly Timothy Edwin (CFO) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Bought 8,000 shares
@ $0.8747, valued at
$7k
|
|
| 03/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/20/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/10/2023 |
SC 13G
| Huang James reports a 5.1% stake in Praxis Precision Medicines, Inc. |
| 03/03/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.2% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 5.9% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in Praxis Precision Medicines, Inc. |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|